Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis

Journal of Experimental Medicine

Volumn 189, Issue 8, 1999, Pages 1195-1205

  Sabelko Downes, Kimberly A ^a   Cross, Anne H ^a   Russell, John H ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept of Molec Biol and Pharmacol ^*  (United States)

Author keywords

Apoptosis; Autoimmunity; Demyelinating disease; Inflammation; T cell regulation

Indexed keywords

FAS LIGAND; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; DEMYELINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FAS LIGAND PROTEIN; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL;

EID: 0033583427     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.8.1195     Document Type: Article

References (34)

1. Panitch, H.S., and D.E. McFarlin. 1977. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J. Immnol. 119:1134-1137.
2. Mokhtarian, F., D.E. McFarlin, and C.S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature. 309:356-358.
3. Ando, D.G., J. Clayton, D. Kono, J.L. Urban, and E.E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132-143.
4. Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A. Janeway, Jr. 1993. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
5. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267:1449-1456.
6. D'souza, S.D., B. Bonetti, V. Balasingam, N.R. Cashman, P.A. Barker, A.B. Troutt, C.S. Raine, and J.P. Antel. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med 184:2361-2370.
7. Howling, P., G. Shang, S. Raval, J. Menonna, S. Cook, and W. Husar. 1996. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1513-1518.
8. Bonetti, B., and C.S. Raine. 1997. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:74-84.
9. Pelfrey, C.M., L.R. Tranquill, S.A. Boehme, H.F. McFarland, and M.J. Lenardo. 1995. Two mechanisms of antigenspecific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154:6191-6202.
10. Ichikawa, H., K. Ota, and M. Iwata. 1996. Increased Fas antigen on T cells in multiple sclerosis. J. Neuroimmunol. 71: 125-129.
11. Sabelko, K.A., K.A. Kelly, M.H. Nahm, A.H. Cross, and J.H. Russell. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immnol. 159:3096-3099.
12. Waldner, H., R.A. Sobel, E. Howard, and V.K. Kuchroo. 1997. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immnol. 159:3100-3103.
13. Malipiero, U., K. Frei, K.S. Spanaus, C. Agresti, H. Lassmann, M. Hahne, J. Tschopp, H.P. Eugster, and A. Fontana. 1997. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perform knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 27:3151-3160.
14. Swanborg, R.H., J.E. Swierkosz, and R.G. Saieg. 1974. Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats. J. Immunol. 112: 594-600.
15. Staats, J. 1979. Mouse and rat. In Inbred and Genetically Defined Strains of Laboratory Animals, Part 1. P.L. Altman and D.D. Katz, editors. FASEB, Bethesda, MD. 21-29.
16. Festing, M.F.W. 1992. Origins and characteristics of inbred strains of mice, 14th listing. Mouse Genome. 90:231-252.
17. Pearson, C.I., W. van Ewijk, and H.O. McDevitt. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 185:583-599.
18. Selmaj, K., C.S. Raine, and A.M. Cross. 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:694-700.
19. Moore, G.R., U. Traugott, M. Farooq, W.T. Norton, and C.S. Raine. 1984. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different niyelin lipids. Lab. Invest. 51:416-424.
20. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
21. Chu, J.L., P. Ramos, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K.B. Elkon. 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393-398.
22. Chervonsky, A.V., Y. Wang, F.S. Wong, I. Visintin, R.A. Flavell, C.A. Janeway, Jr., and L.A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell. 89:17-24.
23. Itoh, N., A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwahashi, M. Moriwaki, H. Nakajima, J. Miyagawa, M. Namba, et al. 1997. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186:613-618.
24. Allison, J., and A. Strasser. 1998. Mechanisms of cell death in diabetes: a minor role for CD95. Proc. Natl. Acad. Sci. USA. 95:13818-13822.
25. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
26. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
27. Shrikant, P., and E.N. Benveniste. 1996. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immnnol. 157:1819-1822.
28. Benveniste, E.N., and D.J. Benos. 1995. TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J. 9:1577-1584.
29. Merrill, J.E., and E.N. Benveniste. 1996. Cytokines in in-flammatory brain lesions: helpful and harmful. Trends Neurosci. 19:331-338.
30. Moller, P., K. Koretz, F. Leithauser, S. Bruderlein, C. Henne, A. Quentmeier, and P.H. Krammer. 1994. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer. 57:371-377.
31. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K.M. Debatin, P.H. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
32. Oyaizu, N., T.W. McCloskey, S. Than, K. Hu, V.S. Kalyanaraman, and S. Pahwa. 1994. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood. 84:2622-2631.
33. Ortiz-Arduan, A., T.M. Danoff, R. Kalluri, S. Gonzalez-Cuadrado, S.L. Karp, K. Elkon, J. Egido, and E.G. Neilson. 1996. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am. J. Physiol. 271:F1193-F1201.
34. Xu, X., X.Y. Fu, J. Plate, and A.S. Chong. 1998. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 58:2832-2837.